This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2005 Mar 3;352(9):930-2.

doi: 10.1056/NEJMe058007.

Risks and benefits of phase 1 oncology trials, revisited

Razelle Kurzrock, Robert S Benjamin

PMID: 15745986
DOI: 10.1056/NEJMe058007

Editorial

Risks and benefits of phase 1 oncology trials, revisited

Razelle Kurzrock et al. N Engl J Med. 2005.

. 2005 Mar 3;352(9):930-2.

doi: 10.1056/NEJMe058007.

Authors

Razelle Kurzrock, Robert S Benjamin

PMID: 15745986
DOI: 10.1056/NEJMe058007

No abstract available

PubMed Disclaimer

Comment in

Phase 1 clinical trials in oncology.
Rothschild BB, King NM. Rothschild BB, et al. N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. doi: 10.1056/NEJM200506093522319. N Engl J Med. 2005. PMID: 15944433 No abstract available.
Phase 1 clinical trials in oncology.
Miller MJ. Miller MJ. N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. N Engl J Med. 2005. PMID: 15948270 No abstract available.
Phase 1 clinical trials in oncology.
Sekine I, Tamura T. Sekine I, et al. N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. N Engl J Med. 2005. PMID: 15948271 No abstract available.

Comment on

Risks and benefits of phase 1 oncology trials, 1991 through 2002.
Horstmann E, McCabe MS, Grochow L, Yamamoto S, Rubinstein L, Budd T, Shoemaker D, Emanuel EJ, Grady C. Horstmann E, et al. N Engl J Med. 2005 Mar 3;352(9):895-904. doi: 10.1056/NEJMsa042220. N Engl J Med. 2005. PMID: 15745980

Similar articles

Phase 1 clinical trials in oncology.
Miller MJ. Miller MJ. N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. N Engl J Med. 2005. PMID: 15948270 No abstract available.
Risks and benefits associated with novel phase 1 oncology trial designs.
Koyfman SA, Agrawal M, Garrett-Mayer E, Krohmal B, Wolf E, Emanuel EJ, Gross CP. Koyfman SA, et al. Cancer. 2007 Sep 1;110(5):1115-24. doi: 10.1002/cncr.22878. Cancer. 2007. PMID: 17628485 Review.
[Clinical phase I studies in oncology and hematology. Concepts, implementation and ethical considerations].
Hanauske AR. Hanauske AR. Med Klin (Munich). 1996 Apr 12;91 Suppl 3:68-70. Med Klin (Munich). 1996. PMID: 8692122 Review. German. No abstract available.
"Therapeutic intent" in phase 1 oncology trials: a justifiable objective.
Markman M. Markman M. Arch Intern Med. 2006 Jul 24;166(14):1446-8. doi: 10.1001/archinte.166.14.1446. Arch Intern Med. 2006. PMID: 16864753 Review. No abstract available.
Phase 1 clinical trials in oncology.
Sekine I, Tamura T. Sekine I, et al. N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. N Engl J Med. 2005. PMID: 15948271 No abstract available.

See all similar articles

Cited by

Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.
Corr BR, Moroney M, Sheeder J, Eckhardt SG, Sawyer B, Behbakht K, Diamond JR. Corr BR, et al. Cancer. 2020 Oct 1;126(19):4289-4293. doi: 10.1002/cncr.33073. Epub 2020 Jul 22. Cancer. 2020. PMID: 32697381 Free PMC article.
The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials.
Iasonos A, Gounder M, Spriggs DR, Gerecitano JF, Hyman DM, Zohar S, O'Quigley J. Iasonos A, et al. Clin Cancer Res. 2012 Oct 1;18(19):5179-87. doi: 10.1158/1078-0432.CCR-12-0726. Epub 2012 Jul 23. Clin Cancer Res. 2012. PMID: 22825582 Free PMC article.
First-In-Human Phase 1 Clinical Trials - A Single-Center Experience In The Era Of Modern Oncotherapeutics.
Paluri RK, Li P, Anderson A, Nandagopal L, McArdle T, Young M, Robert F, Naik G, Saleh M. Paluri RK, et al. Sci Rep. 2020 May 13;10(1):7935. doi: 10.1038/s41598-020-64906-4. Sci Rep. 2020. PMID: 32404970 Free PMC article. Review.
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials.
Lynce F, Blackburn MJ, Cai L, Wang H, Rubinstein L, Harris P, Isaacs C, Pohlmann PR. Lynce F, et al. Breast Cancer Res Treat. 2018 Feb;168(1):35-41. doi: 10.1007/s10549-017-4563-3. Epub 2017 Nov 8. Breast Cancer Res Treat. 2018. PMID: 29119354 Free PMC article.
Research biopsies in the context of early phase oncology studies: clinical and ethical considerations.
Saggese M, Dua D, Simmons E, Lemech C, Arkenau HT. Saggese M, et al. Oncol Rev. 2013 Aug 30;7(1):e5. doi: 10.4081/oncol.2013.e5. eCollection 2013 Apr 22. Oncol Rev. 2013. PMID: 25992226 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.